| Item | DT | Kard | Konf | Beschreibung | Label |
|---|
cda:substanceAdministration
| | | |  Medication Activity SHOULD include doseQuantity OR rateQuantity | Medi vity |
@classCode
| cs | 1 … 1 | F | SBADM | conf‑7496 |
@moodCode
| cs | 1 … 1 | R | | conf‑7497 |
| | CONF | |
hl7:templateId
| II | 1 … 1 | M | | Medivity |
@root
| uid | 1 … 1 | F | 2.16.840.1.113883.3.1937.777.24.10.14 |
cda:templateId
| II | 1 … 1 | M | SHALL contain exactly one [1..1] templateId (CONF:7499) such that it | conf‑7499 |
@root
| uid | 1 … 1 | F | 2.16.840.1.113883.10.20.22.4.16 | conf0504 |
cda:id
| II | 1 … * | R | SHALL contain at least one [1..*] id (CONF:7500). | conf‑7500 |
cda:code
| CD | 0 … 1 | | MAY contain zero or one [0..1] code (CONF:7506). | conf‑7506 |
cda:text
| ED | 0 … 1 | R | SHOULD contain zero or one [0..1] text (CONF:7501). | conf‑7501 |
cda:reference
| | 0 … 1 | R | The text, if present, SHOULD contain zero or one [0..1] reference (CONF:15977). This reference/@value SHALL begin with a '#' and SHALL point to its corresponding narrative (using the approach defined in CDA Release 2, section 4.3.5.1) | conf5977 |
@value
| | 0 … 1 | | | conf5978 |
| | Schematron assert | role |  error | |
| | test | not(@value) or starts-with(@value, '#') | |
| | Meldung | This reference/@value SHALL begin with a '#' and SHALL point to its corresponding narrative (using the approach defined in CDA Release 2, section 4.3.5.1) | |
cda:statusCode
| CS | 1 … 1 | R | SHALL contain exactly one [1..1] statusCode (CONF:7507). | conf‑7507 |
cda:effectiveTime
| IVL_TS | 1 … 1 | M | SHALL contain exactly one [1..1] effectiveTime (CONF:7508) such that it | conf‑7508 |
| wo [not(@operator='A')] | |
cda:low
| TS | 1 … 1 | R | SHALL contain exactly one [1..1] low (CONF:7511). | conf‑7511 |
cda:high
| TS | 1 … 1 | R | SHALL contain exactly one [1..1] high (CONF:7512). | conf‑7512 |
cda:effectiveTime
| SXCM_TS | 0 … 1 | R | SHOULD contain zero or one [0..1] effectiveTime (CONF:7513) such that it SHALL contain exactly one [1..1] @xsi:type=”PIVL_TS” or “EIVL_TS” | conf‑7513 |
| wo [@operator='A'] | |
@operator
| cs | 1 … 1 | F | A | conf‑9106 |
| | Schematron assert | role | error | |
| | test | count(preceding-sibling::cda:effectiveTime) = 1 and .[@operator='A'][@xsi:type='PIVL_TS' or @xsi:type='EIVL_TS'] | |
| | Meldung | SHOULD contain zero or one [0..1] effectiveTime (CONF:7513) such that it | |
cda:repeatNumber
| IVL_INT | 0 … 1 | | MAY contain zero or one [0..1] repeatNumber (CONF:7555). In "INT" (intent) mood, the repeatNumber defines the number of allowed administrations. For example, a repeatNumber of "3" means that the substance can be administered up to 3 times. In "EVN" (event) mood, the repeatNumber is the number of occurrences. For example, a repeatNumber of "3" in a substance administration event means that the current administration is the 3rd in a series. | conf‑7555 |
cda:routeCode
| CE | 0 … 1 | | MAY contain zero or one [0..1] routeCode, which SHALL be selected from ValueSet Medication Route FDA 2.16.840.1.113883.3.88.12.3221.8.7 DYNAMIC (CONF:7514). | conf‑7514 |
| | CONF | |
cda:approachSiteCode
| CD | 0 … 1 | | MAY contain zero or one [0..1] approachSiteCode, where the code SHALL be selected from ValueSet Body Site 2.16.840.1.113883.3.88.12.3221.8.9 DYNAMIC (CONF:7515). | conf‑7515 |
| | CONF | |
| Auswahl | 1 … | |  Medication Activity SHOULD include doseQuantity OR rateQuantity- cda:doseQuantity
- cda:rateQuantity
|
cda:doseQuantity
| IVL_PQ | 0 … 1 | R | SHOULD contain zero or one [0..1] doseQuantity (CONF:7516). Pre-coordinated consumable: If the consumable code is a pre-coordinated unit dose (e.g. "metoprolol 25mg tablet") then doseQuantity is a unitless number that indicates the number of products given per administration (e.g. "2", meaning 2 x "metoprolol 25mg tablet"). Not pre-coordinated consumable: If the consumable code is not pre-coordinated (e.g. is simply "metoprolol"), then doseQuantity must represent a physical quantity with @unit, e.g. "25" and "mg", specifying the amount of product given per administration. | conf‑7516 |
@unit
| cs | 0 … 1 | | | conf‑7526 |
| | CONF | |
cda:rateQuantity
| IVL_PQ | 0 … 1 | | MAY contain zero or one [0..1] rateQuantity (CONF:7517). | conf‑7517 |
@unit
| cs | 1 … 1 | R | | conf‑7525 |
| | CONF | |
cda:maxDoseQuantity
| RTO_PQ_PQ | 0 … 1 | | MAY contain zero or one [0..1] maxDoseQuantity (CONF:7518). | conf‑7518 |
cda:administrationUnitCode
| CE | 0 … 1 | | MAY contain zero or one [0..1] administrationUnitCode, which SHALL be selected from ValueSet Medication Product Form Value Set 2.16.840.1.113883.3.88.12.3221.8.11 DYNAMIC (CONF:7519). | conf‑7519 |
| | CONF | |
cda:consumable
| | 1 … 1 | M | Beinhaltet 2.16.840.1.113883.10.20.22.4.23 Medication Information (2013‑01‑31) | conf‑7520 |
cda:performer
| | 0 … 1 | | MAY contain zero or one [0..1] performer (CONF:7522). | conf‑7522 |
cda:participant
| | 0 … * | | Beinhaltet 2.16.840.1.113883.10.20.22.4.24 Drug Vehicle (2013‑01‑31) | conf‑7523 |
@typeCode
| cs | 1 … 1 | F | CSM | conf‑7524 |
cda:entryRelationship
| | 0 … * | | Beinhaltet 2.16.840.1.113883.10.20.22.4.19 Indication (2013‑01‑31) | conf‑7536 |
@typeCode
| cs | 1 … 1 | F | RSON | conf‑7537 |
cda:entryRelationship
| | 0 … 1 | | Beinhaltet 2.16.840.1.113883.10.20.22.4.20 Instructions (2013‑01‑31) | conf‑7539 |
@typeCode
| cs | 1 … 1 | F | SUBJ | conf‑7540 |
@inversionInd
| bl | 1 … 1 | F | true | conf‑7542 |
cda:entryRelationship
| | 0 … 1 | | Beinhaltet 2.16.840.1.113883.10.20.22.4.17 Medication Supply Order (2013‑01‑31) | conf‑7543 |
@typeCode
| cs | 1 … 1 | F | REFR | conf‑7547 |
cda:entryRelationship
| | 0 … * | | Beinhaltet 2.16.840.1.113883.10.20.22.4.18 Medication Dispense (2013‑01‑31) | conf‑7549 |
@typeCode
| cs | 1 … 1 | F | REFR | conf‑7553 |
cda:entryRelationship
| | 0 … 1 | | Beinhaltet 2.16.840.1.113883.10.20.22.4.9 Reaction Observation (2013‑01‑31) | conf‑7552 |
@typeCode
| cs | 1 … 1 | F | CAUS | conf‑7544 |
cda:precondition
| | 0 … * | | Beinhaltet 2.16.840.1.113883.10.20.22.4.25 Precondition for Substance Administration (2013‑01‑31) | conf‑7546 |
@typeCode
| cs | 1 … 1 | F | PRCN | conf‑7550 |
Entwurf